HKU Scholars Hub: Browsing DSpace

Browsing by Author Ng, MHL

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 9 to 27 of 27 < previous

	Title	Author(s)	Issue Date	Views
	Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations Journal:American Journal of Hematology	Leung, GMK Zhang, C Ng, NKL Yang, N Lam, SSY Au, CH Chan, TL Ma, ESK Tsui, SP Ip, HW So, JCC Ng, MHL Cheng, KCK Wong, KF Siu, LLP Yip, SF Lin , SY Lau, JSM Luk , TH Lee , HKK Lau, CK Kho, B Kwong, YL Leung, AYH	2019	49
	Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7) Journal:Investigational New Drugs	Ma, BBY Lui, VWY Poon, FF Wong, SCC To, KF Wong, E Chen, H Lo, KW Tao, Q Ng, MHL Cheng, SH Chan, ATC	2010
	Exosomal microRNA-486-3p mediates acquired resistance to anaplastic lymphoma kinase inhibitor in EML4-ALK translocated lung adenocarcinoma Proceeding/Conference:Hong Kong Medical Journal	Kwok, HH Ning, Z Chong, PWC Wan, TSK Ng, MHL Ho, GYF Ip, MSM Lam, CLD	2018	1
	The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese Journal:Sleep	Chen, L Fong, SYY Lam, CW Tang, NLS Ng, MHL Li, AM Ho, CKW Cheng, SH Lau, KM Wing, YK	2007	146
	Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation Journal:Investigational New Drugs	Hong, B Lui, VWY Hui, EP Ng, MHL Cheng, SH Sung, FL Tsang, CM Tsao, SW Chan, ATC	2011	200
	Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL 97 study Journal:Hong Kong Medical Journal	Li, CK Chik, KW Ha, SY Lee, ACW Yuen, HL Ling, SC Lee, V Chan, GCF Shing, MMK Chan, LC Ng, MHL	2006
	Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death Journal:Oncogene	Lui, VWY Wong, EYL Ho, K Ng, PKS Lau, CPY Tsui, SKW Tsang, CM Tsao, SW Cheng, SH Ng, MHL Ng, YK Lam, EKY Hong, B Lo, KW Mok, TSK Chan, ATC Mills, GB	2011
	KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas Journal:Cancer Research	Cheng, Y Geng, H Cheng, SH Liang, P Bai, Y Li, J Srivastava, G Ng, MHL Fukagawa, T Wu, X Chan, ATC Tao, Q	2010	134
	Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction Journal:PLoS ONE	Cheng, SH Lau, KM Li, CK Chan, NPH Ip, RKL Cheng, CK Lee, V Shing, MMK Leung, AWK Ha, SY Cheuk, KLD Lee, ACW Li, CH Luk, CW Luk, CW Ling, SC Hrusak, O Mejstrikova, E Leung, Y Ng, MHL	2013	60
	Outcomes of adolescents with acute lymphoblastic leukaemia Journal:Hong Kong Medical Journal	Feng, J Cheng, FWT Chiang, AKS Lam, GKS Chow, TTW Ha, SY Luk, CW Li, CH Ling, SC Yau, PW Ho, KKH Leung, AWK Chan, NPH Ng, MHL Li, CK	2022	4
	Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine Journal:Blood Cancer Discovery	Wang, H Chan, KYY Cheng, CK Ng, MHL Lee, PY Cheng, FWT Lam, GKS Chow, TW Ha, SY Chiang, AKS Leung, WH Leung, AYH Wang, CC Zhang, T Zhang, XB So, CC Yuen, YP Sun, Q Zhang, C Xu, Y Cheung, JTK Ng, WH Tang, PM Kang, W To, KF Lee, WYW Wong, RS Poon, ENY Zhao, Q Huang, J Chen, C Yuen, PMP Li, CK Leung, AWK Leung, KT	2022
	Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma Journal:Investigational New Drugs	Hui, EP Lui, VWY Wong, CSC Ma, BBY Lau, CPY Cheung, CSF Ho, K Cheng, S-H Ng, MHL Chan, ATC	2011	72
	Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models Journal:Cancer Letters	Ma, BBY Lui, VWY Hui, CWC Lau, CPY Wong, CH Hui, EP Ng, MHL Cheng, SH Tsao, SW Tsang, C-M Cheung, CSF Ho, K Chan, ATC	2014	93
	Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1 Journal:Biochemical Pharmacology	Hong, B Lui, VWY Hui, EP Lu, Y Leung, HSY Wong, EYL Cheng, S-H Ng, MHL Mills, GB Chan, ATC	2010	67
	An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation Journal:Biochemical Pharmacology	Lui, VWY Lau, CPY Cheung, CSF Ho, K Ng, MHL Cheng, SH Hong, B Tsao, SW Tsang, CM Lei, KIK Yamasaki, Y Mita, A Chan, ATC	2010	221
	Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth Journal:Cancer Research	Chen, J Zhang, B Wong, N Lo, AWI To, KF Chan, AWH Ng, MHL Ho, CYS Cheng, SH Lai, PBS Yu, J Ng, HK Ling, MT Huang, AL Cai, XF Ko, BCB	2011	225
	A small molecule inhibitor of NF-κB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells Journal:Cancer Letters	Wong, JHT Lui, VWY Umezawa, K Ho, Y Wong, EYL Ng, MHL Cheng, SH Tsang, CM Tsao, SW Chan, ATC	2010	137
	Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma Journal:Biochemical Pharmacology	Zhou, Q Lui, VWY Lau, CPY Cheng, SH Ng, MHL Cai, Y Chan, SL Yeo, W	2012	47
	Transfer of Extracellular Vesicle-Associated-RNAs Induces Drug Resistance in ALK-Translocated Lung Adenocarcinoma Journal:Cancers	Kwok, HH NING, Z Chong, PWC Wan, TSK Ng, MHL Ho, GYF Ip, MSM Lam, DCL	2019	38

Showing results 9 to 27 of 27 < previous